Global CRISPR-Based Diagnostics Market to Reach $9.92 Billion by 2029, Growing at 18% CAGR

What Is the Expected Size and Growth Rate of the CRISPR-Based Diagnostics Market?
Recent years have seen a swift expansion of the CRISPR-based diagnostics market. Estimates predict an increase from $4.35 billion in 2024 to $5.14 billion in 2025, implying a compound annual growth rate (CAGR) of 18.1%. Factors such as heightened healthcare spending, escalating demand for gene editing, increasing occurrence of chronic diseases, improved understanding of treatments, and higher frequency of genetic diseases have all contributed to growth during the historic period.

The market size for CRISPR-based diagnostics is anticipated to significantly expand in the coming years, reaching a value of $9.92 billion in 2029 with a compound annual growth rate (CAGR) of 17.9%. The surge within the forecast period is due to the increasing need for speedy and precise diagnostics, and the expanded use in detecting infectious diseases. Other contributing factors include governmental and institutional financial support, enhanced identification of antibiotic resistance, and a growing understanding and approval of CRISPR technologies. Notable upcoming trends within the forecast period consist of point-of-care (POC) testing, the use of CRISPR-Cas12 and Cas13 systems, personalized medication and genetic testing, coupled with the inclusion of nanotechnology and biosensors, as well as the early detection of diseases using CRISPR.

What Factors Are Fueling Growth in the CRISPR-Based Diagnostics Market?
The growth of the CRISPR-based diagnostics market is anticipated to be propelled by the increasing occurrence of infectious diseases. These diseases, induced by harmful microorganisms like bacteria, viruses, fungi, or parasites, have the ability to spread directly or indirectly among individuals, via contaminated surfaces, food, water, or bugs. Globalization, antibiotic resistance, climate change, urbanization, expanding populations, habitat destruction, and lack of healthcare access are factors contributing to the rise of infectious diseases. CRISPR-based diagnostics bolster the battle against these diseases by offering swift and precise detection of pathogens, enabling early diagnosis, timely action, and effective containment strategies. For example, in August 2024, the UK Health Security Agency published data stating that in England, they recorded 368 measles cases in 2023, a significant escalation compared to 53 cases in 2022-a near sevenfold increase. The West Midlands and London were the key contributors, accounting for 44% and 33% of cases respectively. Consequently, the increasing prevalence of infectious diseases is acting as a catalyst, fuelling the growth of the CRISPR-based diagnostics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp

Which Leading Companies Are Shaping the Growth of the CRISPR-Based Diagnostics Market?
Major companies operating in the CRISPR-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc.

How Is the CRISPR-Based Diagnostics Market Evolving?
Major firms in the CRISPR-based diagnostics market are prioritizing the formation of strategic alliances to augment the availability of swift and precise diagnostics via CRISPR-based point-of-care tests. A strategic alliance constitutes an enduring cooperation between two or more entities that pool their resources and skills to attain mutual objectives and strengthen their competitive edge. For example, in August 2023, CrisprBits Private Limited, a biotech firm based in India, declared a strategic cooperation with Molbio Diagnostics, a molecular diagnostics company also based in India, to produce CRISPR-based Point-of-Care Tests (POCTs). This alliance aims at developing rapid, accurate and cost-efficient diagnostic instruments that utilize CRISPR technology to identify pathogens and genetic markers. These POCTs endeavor to improve diagnostic accessibility in various environments, including areas with limited resources, while guaranteeing rapid and correct disease identification. CrisprBits' expertise in CRISPR-based platforms is combined with Molbio's manufacturing and distribution prowess in this partnership, facilitating the global release of these tests.

What Are the Key Segments of the CRISPR-Based Diagnostics Market?
The CRISPR-based diagnostics market covered in this report is segmented -

1) By Product: Kits, Buffer Solutions, Software, Other Products
2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-mediated Isothermal Amplification (LAMP), Other Techniques
3) By Disease: Infectious Diseases, Non-Infectious Diseases
4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:
1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits
2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers
3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software
4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report

Which Region Dominates the CRISPR-Based Diagnostics Market?
North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR-based diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The CRISPR-Based Diagnostics Global Market Report?

- Market Size Analysis: Analyze the crispr-based diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the crispr-based diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall crispr-based diagnostics market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the crispr-based diagnostics market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20734

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.